Regeneron Repurchases $5B Stake Held by Sanofi as Race for Covid-19 Vaccine Goes On
Regeneron Pharmaceuticals is going to repurchase $5B of its shares from Sanofi without changing their over-a-decade-long partnership as the race for coronavirus vaccine development intensifies.